Seres Therapeutics
MCRB
#10246
Rank
โ‚น0.27 B
Marketcap
โ‚น31.84
Share price
1.11%
Change (1 day)
-58.05%
Change (1 year)

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -โ‚น11.03 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -โ‚น8.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น11.2 Billion34.63%
2023 -โ‚น8.32 Billion-59.97%
2022 -โ‚น20.78 Billion289.57%
2021 -โ‚น5.34 Billion-27.3%
2020 -โ‚น7.34 Billion23%
2019 -โ‚น5.97 Billion-30.11%
2018 -โ‚น8.54 Billion9.73%
2017 -โ‚น7.78 Billion-0.74%
2016 -โ‚น7.84 Billion70.96%
2015 -โ‚น4.59 Billion257.11%
2014 -โ‚น1.29 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น20.69 Billion 84.67%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น21.75 Billion 94.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น36.28 Billion 223.94%๐Ÿ‡บ๐Ÿ‡ธ USA